DMED
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.
DMED
Industry:
Biopharma Medical Pharmaceutical
Founded:
2016-08-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.dmedglobal.com
Total Employee:
11+
Status:
Active
Total Funding:
214 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Mobile Non Scaleable Content Euro Microsoft Azure DNS ASP.NET IIS Pound Sterling
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Encore Dermatology
Encore is a dermatology company that provides prescription therapies and medical devices to dermatologists.
Portal Instruments
Portal Instruments is an early stage company that offers medical device.
Tarsier Pharma
Tarsier Pharma is a late clinical-stage company that develops treatment for autoimmune and inflammatory ocular diseases.
Vetsource
Vetsource provides comprehensive solutions to those who care for pets - veterinarians and pet owners.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-04-28 | Clinipace | Clinipace acquired by dMed | N/A |
Investors List
SpringHill Management
SpringHill Management investment in Series C - dMed
Rock Springs Capital
Rock Springs Capital investment in Series C - dMed
E-Fund
E-Fund investment in Series C - dMed
Sequoia Capital China
Sequoia Capital China investment in Series C - dMed
Kaiser Foundation Hospitals
Kaiser Foundation Hospitals investment in Series C - dMed
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - dMed
Superstring Capital
Superstring Capital investment in Series C - dMed
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - dMed
E-Fund
E-Fund investment in Series C - dMed
Kaiser Permanente
Kaiser Permanente investment in Series C - dMed
Official Site Inspections
http://www.dmedglobal.com Semrush global rank: 6.76 M Semrush visits lastest month: 816
- Host name: 106.14.147.160
- IP address: 106.14.147.160
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "dMed"
dMed Biopharmaceutical Co., Ltd. dba Caidya | LinkedIn
DMed is Now Caidya! Caidya is a global, multi-therapeutic clinical research organization (CRO) dedicated to advancing healthcare innovation and accelerating the development of new …See details»
dMed Biopharmaceutical Company Profile | Management and
Founded in 2016, dMed is a full-service Clinical Contract Research Organization (CRO), and has grown to nearly 700 professional staff covering more than 31 cities in China and three U.S. …See details»
Overview, News & Similar companies - ZoomInfo.com
Apr 28, 2021 View dMed Biopharmaceutical (www.dmedglobal.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well …See details»
CROs dMed and Clinipace merge to accelerate customer success
Jan 28, 2025 SHANGHAI, CHINA and MORRISVILLE, NORTH CAROLINA, USA, April 28, 2021 – dMed Global, a full-service Clinical Contract Research Organization (CRO) based in …See details»
dMed Company Profile - Office Locations, Competitors, Revenue
Jun 25, 2021 dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical …See details»
DMed Global - Facebook
DMed Global. 1 like. About dMed dMed is a full-service Clinical Contract Research Organization (CRO), which provides industry solutions to pharmaceutical and medical device companies in China and...See details»
Caidya eLearning Platform(eLP)
Welcome to dMed Learning Platform ! Search Courses 继续. Support Contact: [email protected]See details»
Recently Merged dMed and Clinipace Announce the Appointment …
May 21, 2021 Founded in 2016, dMed is a full-service Clinical Contract Research Organization (CRO), and has grown to nearly 700 professional staff covering more than 31 cities in China …See details»
dMed - pharmaboardroom.com
Mar 14, 2019 Lingshi Tan – Founder, Chairman and CEO, dMed, China. Dr Lingshi Tan, chairman and CEO of dMed, shares his strategic insights into the new era of Chinese biotech …See details»
缔脉生物医药科技（上海）有限公司
公司邮箱：[email protected] 公司网址：www.dmedglobal.com 一、 关于我们 为什么选择我们？ • 缔脉定位于以高品质服务和专业精神成为业界典范； • 缔脉管理层在中国生物医 …See details»
dMed-Clinipace宣布将公司更名为Caidya(康缔亚) - 美通社
Oct 3, 2022 dMed（缔脉）与Clinipace于2021年4月合并，此次公司品牌变更宣告了dMed和Clinipace原有业务已成功整合。作为整合后统一的品牌，康缔亚彰显了公司"助力全球病患重 …See details»
缔脉生物医药科技（上海）有限公司_药智新闻 - yaozh.com
缔脉生物医药科技（上海）有限公司是一家起源中国、深耕中美、服务于全球医药及医疗器械企业的临床合同研究组织(cro)。See details»
商略达CRO综合管理系统
一体化信息管理提升企业运营效率. 系统支持电话：010-62954148. 综合管理系统See details»
dMed Managed File Transfer - Login - ftp01.dmedglobal.com
English . English; 中文; LoginSee details»
PV11-SOP v.3.0 Pharmacovigilance-Analysis of Similar Events (AOSE)
1. PURPOSE. The purpose of this standard operating procedure (SOP) is to describe the process for the preparation of the Analysis of Similar Events (AOSE).See details»
Daniel Zheng's email & phone | dMed Biopharmaceutical's
May 21, 2021 @dmedglobal.com. Email. Office Address (HQ) 261 Madison Ave Fl 24, New York City, New York, 10016, United States. Office Address (HQ) Reveal for Free . ... Founded in …See details»
CSMA04-SOP Investigator‘s Brochure - learning.dmedglobal.com
PURPOSE . The purpose of this Standard Operating Procedure (SOP) is to describe the requirements and process for developing and updating an Investigator’s Brochure (IB).See details»
DM03-SOP Medical Coding/Related Documents
Purpose. The purpose of this standard operating procedure (SOP) is to describe the process for study coding including the following: · . Dictionary management: WHODrug and MedDRA …See details»
合同研究组织缔脉和Clinipace合并，加速客户成功 | 新闻稿
Apr 29, 2021 合并后的新公司将提供全方位的临床研究服务，以满足全球快速发展的生物技术、制药和医疗器械公司的需求，并加速为全球患者提供创新解决方案。 中国上海和美国北卡罗 …See details»
Yutao Wang Email for dMed - growjo.com
Y****@dmedglobal.com. GROWJO. The Free Company & People Database. Join for Free! Current Roles. dMed Get all of our best features! About ... ‰10å¹´ä»¥ä¸Šå·¥ä½œç» éªŒã€‚ …See details»